Rumors of Pfizer bid boost Bayer...again

Will rumors of a Pfizer bid for Bayer ever die? The talk boosted Bayer's stock in Frankfurt earlier today, despite the bankers who've persistently pooh-poohed the idea. Where there's smoke there's fire, perhaps--or maybe traders just like to talk. Report

Suggested Articles

Imbruvica has enjoyed a nice run in previously untreated CLL over the last few years. But major competition is here in the form of AZ's Calquence.

Pennsylvania's Supreme Court revived thousands of lawsuits alleging the antipsychotic med Risperdal caused males to develop breasts.

In the asthma biologics race, there doesn't appear to be a clear favorite among Xolair, Dupixent, Fasenra and Nucala for a group of pulmonologists.